News

The land rush for specialty pharma business appears to be slowing among privately held specialty pharmacies

Pharmacy option aims to improve members' experience

There are now 11 cell/gene therapies targeting Covid-19 in development

More complex sales cycles, combined with more digitization of the sales process, calls for better engagement tools

UPS is building capacity for -80°C storage; DHL expands in Indianapolis

127,000-sq. ft. facility opens in Libertyville, IL

The PharmaPortal platform is built on IBM’s Blockchain Transparent Supply technology

Morris & Dickson’s president proposes a way forward

Pelican Biothermal’s 2020 study highlights gap between corporate goals and distribution practices

Little hope for a flurry of executive orders that revive drug importation and rebate transactions in Medicare

Survey uncovers key trends in biopharma pursuits for sustainable logistics

Addressing continued hurdles in patient adherence

Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear

PDG will hold a two-day webinar showcasing participating organizations

More warehouse capacity, plus a growing investment in robotics

Passive containers maintain a -20°C temperature spec

Robert Wood Johnson Foundation-sponsored study assesses the situation

Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years

Ed Schoonveld’s compilation on pricing strategies gets updated for the 2020s

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

TransCelerate opens up its network to qualified researchers; Oracle has a new platform

SensiWatch Platform includes analytics and APIs for integrating supply-chain information

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Acquisitions jump BMS and Takeda into Top 10; Amgen and Gilead fall out